SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gaenzle Christopher L

(Last)

(First)

(Middle)

C/O PRA HEALTH SCIENCES, INC.

4130 PARKLAKE AVENUE, SUITE 400

(Street)

RALEIGH

27612

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/24/2020

3. Issuer Name and Ticker or Trading Symbol
PRA Health Sciences, Inc. [ PRAH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Admin Officer & GC

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common stock	39,000⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽²⁾	08/10/2028	Common stock	75,000	$101.42	D
Stock Option (Right to Buy)	⁽³⁾	08/13/2029	Common stock	25,000	$95.94	D

Explanation of Responses:

1. Represents (a) 30,000 shares of restricted stock granted on August 10, 2018 under the issuer's 2018 Stock Incentive Plan (the "Plan"), all of which will vest on August 10, 2021, subject to the holder's continued service through such date, and (b) 9,000 shares of restricted stock granted on August 13, 2019 under the Plan, half of which will vest on August 13, 2020 and half of which will vest on August 13, 2021, subject to the holder's continued service through such dates.

2. The options were granted on August 10, 2018 under the Plan. 18,750 options vested on August 10, 2019 and 18,750 options will vest on each of August 10, 2020, August 10, 2021 and August 10, 2022, subject to the holder's continued service through such dates.

3. The options were granted on August 13, 2019 under the Plan and vest one-third per year on each anniversary of the grant date, subject to the holder's continued service through such dates.

Remarks:

Exhibit 24.1 - Power of Attorney

	By: /s/ Jessica Nielsen Causey	03/02/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.